Showing results (221-230 of 408) with videos related to

Sort By:
Pageof 41
Blood Cancer Journal|September 26, 2021
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E studySanjal H Desai, Betsy LaPlant, William R Macon, et al.
Leukemia & Lymphoma|June 24, 2008
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Susan M Geyer, Paul J Kurtin, et al.
Blood|November 29, 2002
POEMS syndrome: definitions and long-term outcomeAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Blood|January 15, 2005
Proteomic analysis of mantle-cell lymphoma by protein microarrayIrene M Ghobrial, Daniel J McCormick, Scott H Kaufmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2018
Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related DiseaseShounak Majumder, Sonmoon Mohapatra, Ryan J Lennon, et al.
Mayo Clinic Proceedings|January 17, 2003
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myelomaShaji Kumar, Morie A Gertz, Angela Dispenzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosisS Vincent Rajkumar, Ruben A Mesa, Rafael Fonseca, et al.
Seminars in Oncology|February 1, 2017
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphomaLeo I Gordon, Thomas E Witzig, Greg A Wiseman, et al.
Mayo Clinic Proceedings|January 17, 2003
Review of 1027 patients with newly diagnosed multiple myelomaRobert A Kyle, Morie A Gertz, Thomas E Witzig, et al.
Pageof 41